Medline Inc.
MDLNNasdaqCIK 2046386HealthcareFiscal year ends Dec 31
Reports and events: 18 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2120:17 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-26-117844 |
| 2026-10-1520:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-116255 |
| 2026-08-0520:48 ET | 10-Q | Quarterly reportPeriod 2026-06-27 | 0002046386-26-000051 |
| 2026-08-0511:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002046386-26-000049 |
| 2026-07-0920:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-082249 |
| 2026-06-1220:20 ET | 8-K | 5.07 Shareholder vote results | 0002046386-26-000037 |
| 2026-06-0212:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-252557 |
| 2026-05-2011:01 ET | S-1 | Registration statement | 0001193125-26-231691 |
| 2026-05-0620:18 ET | 10-Q | Quarterly reportPeriod 2026-03-28 | 0002046386-26-000026 |
| 2026-05-0611:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002046386-26-000022 |
| 2026-04-2310:05 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001104659-26-047092 |
| 2026-03-0311:57 ET | S-1 | Registration statement | 0001193125-26-086603 |
| 2026-02-2521:51 ET | 10-K | Annual reportPeriod 2025-12-31 | 0002046386-26-000009 |
| 2026-02-2512:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002046386-26-000007 |
| 2025-12-2221:48 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-328884 |
| 2025-12-0820:05 ET | S-1/A | Registration statement, amended | 0001193125-25-311099 |
| 2025-11-0421:28 ET | S-1/A | Registration statement, amended | 0001193125-25-264798 |
| 2025-10-2817:05 ET | S-1 | Registration statement | 0001193125-25-253020 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.